Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

INFLIFE:SV

30.63 EUR 0.18 0.59%

As of 09:14:00 ET on 05/26/2015.

Snapshot for Infond Life (INFLIFE)

Year To Date: +19.68% 3-Month: +5.54% 3-Year: +29.34% 52-Week Range: 21.06 - 31.91
1-Month: -1.99% 1-Year: +45.81% 5-Year: +20.15% Beta vs SBITOP: 0.42

Mutual Fund Chart for INFLIFE

No chart data available.
  • INFLIFE:SV 30.63
  • 1M
  • 1Y
Interactive INFLIFE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for INFLIFE

Infond Life is an open-end investment fund incorporated in Slovenia. The Fund's objective is to invest primarily in companies from healthcare sector. The Fund's objective is capital appreciation.

Inception Date: 06-04-2007 Telephone: 386-2-229-2080
Managers: BARBARA GACNIK
Web Site: www.infond.si

Fundamentals for INFLIFE

NAV (on 2015-05-26) 30.63
Assets (M) (on 2015-05-25) 37.75
Fund Leveraged N
Minimum Investment 12.00
Minimum Subsequent Investment -

Dividends for INFLIFE

No dividends reported

Fees & Expenses for INFLIFE

Front Load 3.00
Back Load 0.00
Current Mgmt Fee 2.25
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 2.33

Top Fund Holdings for INFLIFE

Filing Date: 04/30/2015
Name Position Value % of Total
Novartis AG 18,843 1,731,016 4.770%
Pfizer Inc 52,242 1,567,713 4.320%
Roche Holding AG 5,896 1,509,649 4.160%
Johnson & Johnson 14,604 1,291,912 3.560%
Merck & Co Inc 23,709 1,259,251 3.470%
Gilead Sciences Inc 13,685 1,226,590 3.380%
Bayer AG 8,411 1,085,061 2.990%
Sanofi 12,279 1,085,061 2.990%
Novo Nordisk A/S 20,105 1,008,852 2.780%
Actavis plc 3,813 961,676 2.650%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil